Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

Table 1

Estimated parameters.

Parameters/visits	Screening	Visit 1 at baseline	Visit 2 after 24 months
Anthropometric parameters	+	+	+
Vital signs	+	+	+
Questionnaire survey		+	+
Adiponectin		+	+
GIP		+	+
Leptin		+	+
Ghrelin fasting		+	+
Ghrelin after test		+	+
GLP-1		+	+
НОМА-IR and НОМА-β		+	+
C-peptide fasting		+	+
C-peptide after meal test		+	+
Lipid profile		+	+
HbA1c		+	+
Review of the therapy	+	+	+

2 hours after breakfast in the meal tolerance test.